polymerase PB2 inhibitors (Roche)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namepolymerase PB2 inhibitors (Roche)
Drug Alias Namecap-binding inhibitors (Savira)polymerase PB2 inhibitors (Savira)cap-binding inhibitors (Roche)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPolymerase basic protein 2 inhibitors
TargetsPolymerase basic protein 2
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustriaSwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSavira Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRoche Holding AgSavira Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A